G-protein-coupled receptor signaling in Syk-deficient neutrophils and mast cells

Blood

Volumn 101, Issue 10, 2003, Pages 4155-4163

  Mócsai, Attila ^b   Zhang, Hong ^b   Jakus, Zoltán ^b   Kitaura, Jiro ^b   Kawakami, Toshiaki ^b   Lowell, Clifford A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE; BACTERIAL PROTEIN; CALCIUM ION; CHEMOATTRACTANT; CHEMOATTRACTANT C5 A; EICOSANOID LTB 4; FORMYLMETHIONYLLEUCYLPHENYLALANINE; G PROTEIN COUPLED RECEPTOR; ICOSANOID; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; P 38 MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; ENZYME PRECURSOR; GUANINE NUCLEOTIDE BINDING PROTEIN; SIGNAL PEPTIDE;

ANIMAL CELL; ARTICLE; BONE MARROW; BONE MARROW CELL; CALCIUM SIGNALING; CELL ACTIVITY; CELL MIGRATION; CONTROLLED STUDY; DEGRANULATION; KNOCKOUT MOUSE; MAST CELL; MOUSE; MUTATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN POLYMERIZATION; RESPIRATORY BURST; WILD TYPE; ANIMAL; BLOOD; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ENZYME PRECURSORS; GTP-BINDING PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAST CELLS; MICE; MICE, KNOCKOUT; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

EID: 0142190783     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-07-2346     Document Type: Article

References (52)

1. Chan AC, Shaw AS. Regulation of antigen receptor signal transduction by protein tyrosine kinases. Curr Opin Immunol. 1996;8:394-401.
2. Turner M, Mee PJ, Costello PS, et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature. 1995;378:298-302.
3. Cheng AM, Rowley B, Pao W, Hayday A, Bolen JB, Pawson T. Syk tyrosine kinase required for mouse viability and B-cell development. Nature. 1995;378:303-306.
4. Colucci F, Guy-Grand D, Wilson A, et al. A new look at Syk in αβ and γδ T cell development using chimeric mice with a low competitive hematopoietic environment. J Immunol. 2000;164:5140-5145.
5. Chan AC, Kadlecek TA, Elder ME, et al. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science. 1994;264:1599-1601.
6. Elder ME, Lin D, Clever J, et al. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science. 1994;264:1596-1599.
7. Negishi I, Motoyama N, Nakayama K, et al. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature. 1995;376:435-438.
8. Costello PS, Turner M, Walters AE, et al. Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene. 1996;13:2595-2605.
9. cγ receptors on macrophages. J Exp Med. 1997;186:1027-1039.
10. cγ receptor signaling in macrophages and neutrophils. Mol Cell Biol. 1998;18:4209-4220.
11. c receptor γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J. 1997;16:2333-2341.
12. Mócsai A, Zhou M, Meng F, Tybulewicz VL, Lowell CA. Syk is required for integrin signaling in neutrophils. Immunity. 2002;16:547-558.
13. 3 initiate integrin signaling to the cytoskeleton. J Cell Biol. 2002;157:265-275.
14. 2 integrin receptor and Syk kinase signaling in monocytes by the Src family kinase Fgr. Immunity. 2001;15:507-519.
15. , Coopman PJ, Do MT, Barth M, et al. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature. 2000;406:742-747.
16. Yanagi S, Inatome R, Ding J, Kitaguchi H, Tybulewicz VL, Yamamura H. Syk expression in endothelial cells and their morphologic defects in embryonic Syk-deficient mice. Blood. 2001;98:2869-2871.
17. Yanagi S, Inatome R, Takano T, Yamamura H. Syk expression and novel function in a wide variety of tissues. Biochem Biophys Res Commun. 2001;288:495-498.
18. Wan Y, Bence K, Hata A, Kurosaki T, Veillette A, Huang XY. Genetic evidence for a tyrosine kinase cascade preceding the mitogen-activated protein kinase cascade in vertebrate G-protein signaling. J Biol Chem. 1997;272:17209-17215.
19. Wan Y, Kurosaki T, Huang XY. Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors. Nature. 1996;380:541-544.
20. Ganju RK, Brubaker SA, Chernock RD, Avraham S, Groopman JE. β-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. J Biol Chem. 2000;275:17263-17268.
21. Tsuchida S, Yanagi S, Inatome R, et al. Purification of a 72-kDa protein-tyrosine kinase from rat liver and its identification as Syk: involvement of Syk in signaling events of hepatocytes. J Biochem (Tokyo). 2000;127:321-327.
22. Cambien B, Pomeranz M, Millet MA, Rossi B, Schmid-Alliana A. Signal transduction involved in MCP-1-mediated monocytic transendothelial migration. Blood. 2001;97:359-366.
23. Cambien B, Pomeranz M, Schmid-Antomarchi H, et al. Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood. 2001;97:2031-2037.
24. I-mediated activation of the Syk kinase by the receptor mimetic basic secretagogues of mast cells: role in mediating arachidonic acid/metabolites release. J Immunol. 2001;167:475-481.
25. sα repression of adipogenesis via Syk. J Biol Chem. 1999;274:32159-32166.
26. CεR1 is not shared by a G protein-coupled receptor. J Biol Chem. 1995;270:10960-10967.
27. Mócsai A, Jakus Z, Vántus T, Berton G, Lowell CA, Ligeti E. Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases. J Immunol. 2000;164:4321-4331.
28. 3. EMBO J. 1997;16:6414-6425.
29. 3 signaling in platelets. Blood. 1999;93:2645-2652.
30. Miura K, Lavens-Phillips S, MacGlashan DW Jr. Piceatannol is an effective inhibitor of IgE-mediated secretion from human basophils but is neither selective for this receptor nor acts on Syk kinase at concentrations where mediator release inhibition occurs. Clin Exp Allergy. 2001;31:1732-1739.
31. Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature. 1996;383:547-550.
32. i- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J Biol Chem. 1997;272:19125-19132.
33. 2 adrenergic receptor-Src protein kinase complexes. Science. 1999;283:655-661.
34. Mócsai A, Ligeti E, Lowell CA, Berton G. Adhesion-dependent degranulation of neutrophils requires the Src family kinases Fgr and Hck. J Immunol. 1999;162:1120-1126.
35. Meng F, Lowell CA. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J Exp Med. 1997;185:1661-1670.
36. Kadlecek TA, van Oers NS, Lefrancois L, et al. Differential requirements for ZAP-70 in TCR signaling and T cell development. J Immunol. 1998;161:4688-4694.
37. Sklar LA, McNeil VM, Jesaitis AJ, Painter RG, Cochrane CG. A continuous, spectroscopic analysis of the kinetics of elastase secretion by neutrophils: the dependence of secretion upon receptor occupancy. J Biol Chem. 1982;257:5471-5475.
38. 2+ influx in human neutrophil granulocytes: alterations in chronic granulomatous disease. J Biol Chem. 1997;272:26471-26478.
39. Rebres RA, Vaz LE, Green JM, Brown EJ. Normal ligand binding and signaling by CD47 (integrin-associated protein) requires a long range disulfide bond between the extracellular and membrane-spanning domains. J Biol Chem. 2001;276:34607-34616.
40. Henson PM, Henson JE, Fittschen C, Bratton DL, Riches DWH. Degranulation and secretion by phagocytic cells. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. 2nd ed. New York, New York: Raven Press; 1992:511.
41. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997;89:3503-3521.
42. Hopken UE, Lu B, Gerard NP, Gerard C. The CSa chemoattractant receptor mediates mucosal defence to infection. Nature. 1996;383:86-89.
43. Crooks SW, Stockley RA. Leukotriene B4. Int J Biochem Cell Biol. 1998;30:173-178.
44. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436-445.
45. Baggiolini M. Chemokines in pathology and medicine. J Intern Med. 2001;250:91-104.
46. Murphy PM, Baggiolini M, Charo IF, et al. International union of pharmacology, XXII: nomenclature for chemokine receptors. Pharmacol Rev. 2000;52:145-176.
47. Cacalano G, Lee J, Kikly K, et al. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science. 1994;265:682-684.
48. Laffargue M, Calvez R, Finan P, et al. Phosphoinositide 3-kinase γ is an essential amplifier of mast cell function. Immunity. 2002;16:441-451.
49. Ferrigni NR, McLaughlin JL, Powell RG, Smith CR Jr. Use of potato disc and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia lagascae. J Nat Prod. 1984;47:347-352.
50. Tsuruga T, Chun YT, Ebizuka Y, Sankawa U. Biologically active constituents of Melaleuca leucadendron: inhibitors of induced histamine release from rat mast cells. Chem Pharm Bull (Tokyo). 1991;39:3276-3278.
51. Geahlen RL, McLaughlin JL. Piceatannol (3,4,3′,5′-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor. Biochem Biophys Res Commun. 1989;165:241-245.
52. CεR1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J Biol Chem. 1994;269:29697-29703.